Futures in Life Science Series
About the FILS Event Series Partnership
Propel Careers, MassBio, and the MassBioEd joined together in 2011 to organize a series of networking and panel events focused on raising awareness of career paths that exist in life sciences for individuals with advanced degrees. This Futures in Life Science program brings together experts across a wide range of disciplines and functional areas within the life science industry to detail their roles and provide a rich context for the audience to gain a clear understanding of the skills, aptitudes, competencies, and personalities that thrive in their particular functions. Attendance for this program is open to current graduate students, post doctoral fellows, and medical residents who are interested in careers in the life sciences industry. The goal of these events is to profile the various career paths including business, commercial, consulting, research and development, clinical, medical affairs, regulatory, bioinformatics systems biology, reimbursement, pharmacoeconomics, patient advocacy, finance, legal and operations. Since 2011, more than 1,500 individuals have attended these events.
Individuals from the following companies have participated on panels during this series
Novartis Institute for Biomedical Sciences, Ironwood Pharmaceuticals, Satori Pharmaceuticals, Cubist, GNS Healthcare, EMD Serono, Inc, Polaris Ventures, Cooley LLP, Genzyme, Extera Partners Merrimack Pharmaceuticals, Verastem, Merck Research Laboratories, KCAS Laboratories, Halloran Consulting Group, Synageva BioPharma, Kala Pharmaceuticals, Link Medicine, INC Research Tessella Inc, Metrum Research Group, Sanofi Pasteur Biologics, Collaborative Consulting, LLC Medimmune, Analysis Group, Wolf Greenfield, Cerulean Pharmaceuticals, Sanofi-aventis, Safety Partners, Inc., Cytel, Inc, Third Rock Ventures, Health Advances Atlas Venture, Deallus Group, Putnam Associates, Lumleian, LLC, Children’s Hospital Boston, Genzyme Ventures, TrialNetworks, Sample6 Technologies, Inc, Epizyme, Sanofi Oncology, EMD Millipore, AstraZeneca Pharmaceuticals LP, Vertex Pharmaceuticals, Biogen Idec, GfK Bridgehead, Global Prior Art, Addgene, Sarepta Therapeutics